Search For "pharma"
Pfizer indicated to provide COVID-19 vaccine in July, requested indemnity
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI): The Central government is in discussions with Pfizer as the American Pharmaceutical company has indicated to provide its COVID-19 vaccine possibly in July, informed Dr VK Paul, Chair of the National Expert Group on Vaccine Administration (NEGVAC) for COVID
Read More
Sun Pharma clocks Rs 894 crore net profit in March quarter
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 27 (ANI): Sun Pharmaceutical Industries on Thursday posted 124 per cent increase in consolidated net profit at Rs 894 crore for the January to March quarter as compared to Rs 400 crore in the year-ago period.
Read More
TradeIndia set to organize India's first Medical and Healthcare Expo India
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI/BusinessWire India): TradeIndia, the country's leading B2B online marketplace platform, is preparing to host its ninth landmark virtual event, the Medical and Healthcare Expo India 2021.
Read More
Zydus Cadila Q4 net profit up 73 pc at Rs 679 crore
Updated : 4 years, 9 months ago IST
Ahmedabad (Gujarat) [India], May 27 (ANI): Pharmaceutical major Zydus Cadila said on Thursday its net profit jumped 73 per cent year-on-year to Rs 679 crore during the quarter ended March.
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Pfizer tells Centre its vaccine suitable for 12 years and above
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI): American pharmaceutical giant Pfizer on Wednesday informs the Central government that its COVID-19 vaccine is suitable for all aged 12 and above and can be stored at 2-8 degrees for over a month, according to the sources.
Read More
Pfizer to send 50 million COVID-19 vaccines to India with conditions
Updated : 4 years, 9 months ago IST
New Delhi [India], May 26 (ANI): US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.
Read More
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Harish C Rijhwani launches his third book 'Master the Mystic Arts' - Data
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 25 (ANI/Connect360PR): Healthcare IT professional Harish C. Rijhwani launched his third book titled 'Master The Mystic Arts'.
Read More
RDIF, Panacea Biotec launch production of Sputnik V COVID-19 vaccine in In
Updated : 4 years, 9 months ago IST
Moscow [Russia], May 24 (ANI): The Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, on Monday launched the production of the Sputnik V COVID-19 vaccine.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 3
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, the generic version of F
Read More
Equity indices flat in volatile trade, pharma stocks gain
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 24 (ANI): Equity benchmark indices were flat in volatile trade during early hours on Monday with pharma scrips gaining some ground.
Read More